Strategic partnerships Ayana Bio collaborates with Ginkgo Bioworks and Brevel to scale plant cell-cultivated ingredients, indicating a strong channel for co-developed high-value bioactives and potential joint go-to-market opportunities with fermentation and synthetic biology platforms.

Industrial-scale potential The integration with Brevel’s illuminated fermentation and Ayana Bio’s plant cell cultivation suggests a scalable indoor manufacturing pipeline, presenting opportunities to offer reliable, location-flexible supply of botanicals to food, supplements, cosmetics, and animal care customers.

Sustainability and safety Standardized plant and fungal bioactives produced via cell culture align with demand for sustainable, traceable ingredients, presenting a compelling value proposition for brands seeking reliable quality, safety assurances, and ESG-aligned sourcing.

Market entry readiness With a recent publicized collaboration and a Plant Cell Advantage platform, there is a narrative and educational angle to accelerate customer onboarding, helping brands understand plant-cell derived ingredients and reducing market education time.

Funding and growth signals Recent grant support from BIRD Foundation and high-profile investors indicate validated expansion potential and financial backing, enabling sales teams to pursue strategicTier customers in food, dietary supplements, cosmetics, and animal care with confidence.